REPORTS

Let’s Pullulate and Expand Your Business

Intravenous Iron Drug Market - Global Professional Analysis and Forecast to 2026

Oct 14, 2019  |  184 PAGES  |  REPORT CODE: CMM210470
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Intravenous Iron Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.1% during the forecast period.

This report presents the market size and development trends by detailing the Intravenous Iron Drug market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Intravenous Iron Drug market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Intravenous Iron Drug industry and will help you to build a panoramic view of the industrial development.

Intravenous Iron Drug Market, By Type:

  • Ferric carboxymaltose

  • Iron Sucrose

  • Iron Dextran

  • Others

Intravenous Iron Drug Market, By Application:

  • Nephrology

  • Gynecology & Obstetrics

  • Gastroenterology

  • Oncology

  • Cardiology

  • Others

Some of the leading players are as follows:

  • Allergan Plc

  • AMAG Pharmaceuticals, Inc.

  • Luitpold Pharmaceuticals, Inc.

  • Pharmacosmos A/S

  • Sanofi US

  • Daiichi Sankyo, Inc.

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Intravenous Iron Drug Market: Technology Type Analysis

  • 4.1 Intravenous Iron Drug Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Intravenous Iron Drug Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Ferric carboxymaltose

    • 4.3.2 Iron Sucrose

    • 4.3.3 Iron Dextran

    • 4.3.4 Others

5 Intravenous Iron Drug Market: Product Analysis

  • 5.1 Intravenous Iron Drug Product Market Share Analysis, 2018 & 2026

  • 5.2 Intravenous Iron Drug Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Intravenous Iron Drug Market: Application Analysis

  • 6.1 Intravenous Iron Drug Application Market Share Analysis, 2018 & 2026

  • 6.2 Intravenous Iron Drug Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Nephrology

    • 6.3.2 Gynecology & Obstetrics

    • 6.3.3 Gastroenterology

    • 6.3.4 Oncology

    • 6.3.5 Cardiology

    • 6.3.6 Others

7 Intravenous Iron Drug Market: Regional Analysis

  • 7.1 Intravenous Iron Drug Regional Market Share Analysis, 2018 & 2026

  • 7.2 Intravenous Iron Drug Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Allergan Plc

    • 9.1.1 Allergan Plc Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 AMAG Pharmaceuticals, Inc.

    • 9.2.1 AMAG Pharmaceuticals, Inc. Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Luitpold Pharmaceuticals, Inc.

    • 9.3.1 Luitpold Pharmaceuticals, Inc. Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Pharmacosmos A/S

    • 9.4.1 Pharmacosmos A/S Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Sanofi US

    • 9.5.1 Sanofi US Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Daiichi Sankyo, Inc.

    • 9.6.1 Daiichi Sankyo, Inc. Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

 

The List of Tables and Figures (Totals 102 Figures and 161 Tables)

  • Figure Ferric carboxymaltose Intravenous Iron Drug market, 2015 - 2026 (USD Million)

  • Figure Iron Sucrose Intravenous Iron Drug market, 2015 - 2026 (USD Million)

  • Figure Iron Dextran Intravenous Iron Drug market, 2015 - 2026 (USD Million)

  • Figure Others Intravenous Iron Drug market, 2015 - 2026 (USD Million)

  • Figure Nephrology market, 2015 - 2026 (USD Million)

  • Figure Gynecology & Obstetrics market, 2015 - 2026 (USD Million)

  • Figure Gastroenterology market, 2015 - 2026 (USD Million)

  • Figure Oncology market, 2015 - 2026 (USD Million)

  • Figure Cardiology market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Intravenous Iron Drug market, by country, 2015 - 2026 (USD Million)

  • Table North America Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table North America Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table North America Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table Canada Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table Canada Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Europe Intravenous Iron Drug market, by country, 2015 - 2026 (USD Million)

  • Table Europe Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table Europe Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table Europe Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table Germany Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table Germany Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table France Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table France Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table Italy Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table Italy Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table Spain Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table Spain Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Intravenous Iron Drug market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table China Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table China Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table Japan Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table Japan Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table India Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table India Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Intravenous Iron Drug market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table MEA Intravenous Iron Drug market, by country, 2015 - 2026 (USD Million)

  • Table MEA Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table MEA Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table MEA Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Intravenous Iron Drug market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Intravenous Iron Drug market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Intravenous Iron Drug market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Allergan Plc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AMAG Pharmaceuticals, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Luitpold Pharmaceuticals, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pharmacosmos A/S Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi US Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Daiichi Sankyo, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top